Feasibility of FMISO in Brain Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This phase II trial studies how well 18F- fluoromisonidazole (FMISO) works with positron emission tomography (PET)/magnetic resonance imaging (MRI) in assessing participants with malignant (cancerous) brain tumors. Two contrast agents called gadolinium and ferumoxytol are used during some of the MRI scans. A contrast agent is a liquid-like dye that is given intravenously (IV) to help imaging machines create pictures. The study drug, called FMISO, provides information about the oxygen levels in a tumor, which may affect how the tumor behaves. PET/MRI imaging produces images of the brain and how the body functions. FMISO PET/MRI may help investigators see how much oxygen is getting in the brain tumors.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorośli (18 lat i starsi) z podejrzeniem guza mózgu (glioma)
- •Guz w mózgu większy niż 5 mL widoczny w badaniu MRI
- •Ogólny stan zdrowia pozwalający na udział w badaniu
- •Spodziewana długość życia co najmniej 6 miesięcy
- •Wcześniej leczony guz mózgu lub zgoda na standardowe leczenie (operacja i chemioterapia)
- •U kobiet zdolnych do zajścia w ciążę: ujemny test ciążowy przed badaniem
- •Prawidłowa funkcja nerek, wątroby i innych narządów
✗ Disqualifies
- •Ciąża lub karmienie piersią
- •Przeciwwskazania do tomografii PET, MRI lub badanego leku FMISO
- •Nieskontrolowana klaustrofobia
- •Uczulenie na kontrastowe środki diagnostyczne
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
OHSU Knight Cancer Institute
Portland, United States
Trial contact
Ramon Barajas
Ramon Barajas
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.